Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gangyang Wang

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 17, 2020
Corrigendum to "HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1" [Biochim. Biophys. Acta Mol. Basis Dis. 1864 (2018) 1839-1849]Hongsheng Wang, Wei Sun, Mengxiong Sun, et al.
International Journal of Cancer|February 6, 2019
Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcomaGangyang Wang, Mengxiong Sun, Yafei Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2019
Inhibition of CaMKIIα Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic DegradationJing Xu, Hongsheng Wang, Yi Hu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 11, 2018
HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1Hongsheng Wang, Wei Sun, Mengxiong Sun, et al.
Frontiers in Oncology|June 25, 2021
Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 SignalingYafei Jiang, Gangyang Wang, Haoran Mu, et al.
Nature Communications|November 23, 2022
Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatmentYafei Jiang, Jinzeng Wang, Mengxiong Sun, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 17, 2020
Corrigendum to "HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1" [Biochim. Biophys. Acta Mol. Basis Dis. 1864 (2018) 1839-1849]Hongsheng Wang, Wei Sun, Mengxiong Sun, et al.
International Journal of Cancer|February 6, 2019
Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcomaGangyang Wang, Mengxiong Sun, Yafei Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2019
Inhibition of CaMKIIα Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic DegradationJing Xu, Hongsheng Wang, Yi Hu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 11, 2018
HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1Hongsheng Wang, Wei Sun, Mengxiong Sun, et al.
Frontiers in Oncology|June 25, 2021
Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 SignalingYafei Jiang, Gangyang Wang, Haoran Mu, et al.
Nature Communications|November 23, 2022
Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatmentYafei Jiang, Jinzeng Wang, Mengxiong Sun, et al.
Pageof 4